Stock Comparison

KYMR vs VRTX

Kymera Therapeutics Inc and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

KYMR

Kymera Therapeutics Inc

Healthcare

VRTX

Vertex Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$9.32B

$123.94B

P/E (TTM)

—

28.5

Forward P/E

—

25.7

Price/Sales

88.8

9.9

Price/Book

6.3

6.1

EV/EBITDA

-10.0

23.2

Dividend Yield

—

Profitability

Net Margin

-612.17%

35.40%

Operating Margin

-697.81%

38.97%

Return on Equity

-24.10%

23.50%

Return on Assets

-15.60%

11.90%

Growth (YoY)

Revenue Growth

466.40%

12.50%

Earnings Growth

0.00%

8.00%

Price & Risk

Beta

2.0

0.3

52-Week High

$119.35

$529.65

52-Week Low

$40.69

$376.62

Analyst Target

$131.00

$559.28

Compare KYMR and VRTX your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.